Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001722430 | SCV000601630 | likely benign | not provided | 2021-05-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000535119 | SCV000639258 | likely benign | Familial adenomatous polyposis 2 | 2024-01-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000575994 | SCV000662596 | likely benign | Hereditary cancer-predisposing syndrome | 2015-05-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000575994 | SCV000690507 | likely benign | Hereditary cancer-predisposing syndrome | 2017-02-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001722430 | SCV000723071 | likely benign | not provided | 2019-07-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000506292 | SCV001426953 | likely benign | not specified | 2020-07-30 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000535119 | SCV004835433 | likely benign | Familial adenomatous polyposis 2 | 2023-11-02 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000506292 | SCV005090553 | likely benign | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing |